nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—Tachykinin receptors bind tachykinins—TAC1—atopic dermatitis	0.0691	0.228	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CCR3—atopic dermatitis	0.00898	0.0296	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00804	0.0265	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CXCR3—atopic dermatitis	0.00785	0.0259	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00717	0.0236	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00643	0.0212	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00539	0.0178	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00518	0.0171	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CCR5—atopic dermatitis	0.00492	0.0162	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00481	0.0158	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL13—atopic dermatitis	0.00479	0.0158	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	0.00441	0.0145	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CXCL10—atopic dermatitis	0.00437	0.0144	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00431	0.0142	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00422	0.0139	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL22—atopic dermatitis	0.00411	0.0135	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—BDNF—atopic dermatitis	0.00392	0.0129	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.00381	0.0126	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—NPS—atopic dermatitis	0.00381	0.0126	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00376	0.0124	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00376	0.0124	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00369	0.0122	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL27—atopic dermatitis	0.00366	0.0121	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL4—atopic dermatitis	0.00364	0.012	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00348	0.0114	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00341	0.0112	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00341	0.0112	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL17—atopic dermatitis	0.00328	0.0108	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	0.00314	0.0103	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL10—atopic dermatitis	0.003	0.00987	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00298	0.00983	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00283	0.00933	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—NGF—atopic dermatitis	0.00279	0.00918	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL11—atopic dermatitis	0.00265	0.00872	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00257	0.00846	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00253	0.00832	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00253	0.00832	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00248	0.00816	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00231	0.00762	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IFNG—atopic dermatitis	0.0022	0.00726	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR3—atopic dermatitis	0.00216	0.00711	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL22—atopic dermatitis	0.00211	0.00694	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00207	0.00681	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CXCL8—atopic dermatitis	0.00205	0.00675	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.002	0.00659	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1B—atopic dermatitis	0.00196	0.00647	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL2—atopic dermatitis	0.00196	0.00645	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—TAC1—atopic dermatitis	0.00192	0.00633	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—NPS—atopic dermatitis	0.00192	0.00633	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00189	0.00621	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL27—atopic dermatitis	0.00188	0.00619	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00172	0.00568	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL17—atopic dermatitis	0.00169	0.00555	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.00164	0.0054	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	0.00157	0.00518	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00155	0.00511	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00152	0.00502	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—atopic dermatitis	0.00143	0.0047	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.0014	0.00461	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL11—atopic dermatitis	0.00136	0.00447	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FCER2—atopic dermatitis	0.00134	0.00441	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL5—atopic dermatitis	0.00131	0.00432	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL22—atopic dermatitis	0.00125	0.0041	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00122	0.00402	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR5—atopic dermatitis	0.00118	0.00389	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL6—atopic dermatitis	0.00115	0.00379	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—atopic dermatitis	0.00114	0.00376	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL27—atopic dermatitis	0.00111	0.00366	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR3—atopic dermatitis	0.00111	0.00365	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—TAC1—atopic dermatitis	0.00109	0.00358	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—NPS—atopic dermatitis	0.00109	0.00358	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00107	0.00351	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—IL5—atopic dermatitis	0.00101	0.00333	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL17—atopic dermatitis	0.000995	0.00328	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—NPS—atopic dermatitis	0.000987	0.00325	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TAC1—atopic dermatitis	0.000987	0.00325	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000968	0.00319	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000939	0.00309	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6—atopic dermatitis	0.00092	0.00303	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL5—atopic dermatitis	0.000917	0.00302	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KIF3A—atopic dermatitis	0.000887	0.00292	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000861	0.00284	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL11—atopic dermatitis	0.000802	0.00264	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CMA1—atopic dermatitis	0.000802	0.00264	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000782	0.00258	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—STAT6—atopic dermatitis	0.000754	0.00248	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000742	0.00244	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000715	0.00235	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000712	0.00235	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL5—atopic dermatitis	0.000673	0.00222	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000668	0.0022	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR3—atopic dermatitis	0.000654	0.00215	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR5—atopic dermatitis	0.000607	0.002	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TAC1—atopic dermatitis	0.000583	0.00192	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPS—atopic dermatitis	0.000583	0.00192	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCR3—atopic dermatitis	0.000572	0.00188	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL5—atopic dermatitis	0.000542	0.00179	CbGpPWpGaD
Fosaprepitant—Malaise—Prednisolone—atopic dermatitis	0.000516	0.000741	CcSEcCtD
Fosaprepitant—Dysgeusia—Triamcinolone—atopic dermatitis	0.000515	0.00074	CcSEcCtD
Fosaprepitant—Syncope—Prednisolone—atopic dermatitis	0.000513	0.000737	CcSEcCtD
Fosaprepitant—Eye disorder—Betamethasone—atopic dermatitis	0.000512	0.000736	CcSEcCtD
Fosaprepitant—Eye disorder—Dexamethasone—atopic dermatitis	0.000512	0.000736	CcSEcCtD
Fosaprepitant—Angioedema—Hydrocortisone—atopic dermatitis	0.000511	0.000733	CcSEcCtD
Fosaprepitant—Malaise—Hydrocortisone—atopic dermatitis	0.000504	0.000723	CcSEcCtD
Fosaprepitant—Loss of consciousness—Prednisolone—atopic dermatitis	0.000503	0.000722	CcSEcCtD
Fosaprepitant—Syncope—Hydrocortisone—atopic dermatitis	0.000501	0.000719	CcSEcCtD
Fosaprepitant—Diarrhoea—Tacrolimus—atopic dermatitis	0.0005	0.000718	CcSEcCtD
Fosaprepitant—Angiopathy—Betamethasone—atopic dermatitis	0.000498	0.000714	CcSEcCtD
Fosaprepitant—Angiopathy—Dexamethasone—atopic dermatitis	0.000498	0.000714	CcSEcCtD
Fosaprepitant—Hypertension—Prednisolone—atopic dermatitis	0.000494	0.000709	CcSEcCtD
Fosaprepitant—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000491	0.000705	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000488	0.000701	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000487	0.000699	CcSEcCtD
Fosaprepitant—Bradycardia—Prednisone—atopic dermatitis	0.000486	0.000698	CcSEcCtD
Fosaprepitant—Dizziness—Tacrolimus—atopic dermatitis	0.000483	0.000694	CcSEcCtD
Fosaprepitant—Hypertension—Hydrocortisone—atopic dermatitis	0.000482	0.000693	CcSEcCtD
Fosaprepitant—Discomfort—Prednisolone—atopic dermatitis	0.000481	0.000691	CcSEcCtD
Fosaprepitant—Angioedema—Triamcinolone—atopic dermatitis	0.000481	0.00069	CcSEcCtD
Fosaprepitant—Angioedema—Methylprednisolone—atopic dermatitis	0.00048	0.000689	CcSEcCtD
Fosaprepitant—Erythema—Dexamethasone—atopic dermatitis	0.000477	0.000685	CcSEcCtD
Fosaprepitant—Erythema—Betamethasone—atopic dermatitis	0.000477	0.000685	CcSEcCtD
Fosaprepitant—Malaise—Triamcinolone—atopic dermatitis	0.000474	0.000681	CcSEcCtD
Fosaprepitant—Anxiety—Hydrocortisone—atopic dermatitis	0.000474	0.000681	CcSEcCtD
Fosaprepitant—Malaise—Methylprednisolone—atopic dermatitis	0.000473	0.00068	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000472	0.000678	CcSEcCtD
Fosaprepitant—Syncope—Triamcinolone—atopic dermatitis	0.000472	0.000677	CcSEcCtD
Fosaprepitant—Syncope—Methylprednisolone—atopic dermatitis	0.000471	0.000676	CcSEcCtD
Fosaprepitant—Discomfort—Hydrocortisone—atopic dermatitis	0.00047	0.000675	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Prednisone—atopic dermatitis	0.000469	0.000674	CcSEcCtD
Fosaprepitant—Oedema—Prednisolone—atopic dermatitis	0.000467	0.00067	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000467	0.00067	CcSEcCtD
Fosaprepitant—Vomiting—Tacrolimus—atopic dermatitis	0.000465	0.000667	CcSEcCtD
Fosaprepitant—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000462	0.000664	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CXCL10—atopic dermatitis	0.000462	0.00152	CbGpPWpGaD
Fosaprepitant—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000461	0.000662	CcSEcCtD
Fosaprepitant—Rash—Tacrolimus—atopic dermatitis	0.000461	0.000662	CcSEcCtD
Fosaprepitant—Dermatitis—Tacrolimus—atopic dermatitis	0.00046	0.000661	CcSEcCtD
Fosaprepitant—Shock—Prednisolone—atopic dermatitis	0.000459	0.00066	CcSEcCtD
Fosaprepitant—Cough—Triamcinolone—atopic dermatitis	0.000459	0.000659	CcSEcCtD
Fosaprepitant—Headache—Tacrolimus—atopic dermatitis	0.000458	0.000658	CcSEcCtD
Fosaprepitant—Oedema—Hydrocortisone—atopic dermatitis	0.000456	0.000655	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000456	0.000655	CcSEcCtD
Fosaprepitant—Hypertension—Triamcinolone—atopic dermatitis	0.000454	0.000652	CcSEcCtD
Fosaprepitant—Hypertension—Methylprednisolone—atopic dermatitis	0.000453	0.000651	CcSEcCtD
Fosaprepitant—Infection—Hydrocortisone—atopic dermatitis	0.000453	0.00065	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000451	0.000648	CcSEcCtD
Fosaprepitant—Shock—Hydrocortisone—atopic dermatitis	0.000449	0.000644	CcSEcCtD
Fosaprepitant—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000447	0.000642	CcSEcCtD
Fosaprepitant—Eye disorder—Prednisone—atopic dermatitis	0.000446	0.000641	CcSEcCtD
Fosaprepitant—Anxiety—Methylprednisolone—atopic dermatitis	0.000445	0.000639	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000444	0.000637	CcSEcCtD
Fosaprepitant—Flushing—Prednisone—atopic dermatitis	0.000443	0.000636	CcSEcCtD
Fosaprepitant—Skin disorder—Hydrocortisone—atopic dermatitis	0.000443	0.000636	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000443	0.000636	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000443	0.000636	CcSEcCtD
Fosaprepitant—Discomfort—Triamcinolone—atopic dermatitis	0.000443	0.000635	CcSEcCtD
Fosaprepitant—Discomfort—Methylprednisolone—atopic dermatitis	0.000442	0.000634	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000441	0.000633	CcSEcCtD
Fosaprepitant—Dry mouth—Triamcinolone—atopic dermatitis	0.000438	0.000629	CcSEcCtD
Fosaprepitant—Angioedema—Betamethasone—atopic dermatitis	0.000436	0.000626	CcSEcCtD
Fosaprepitant—Angioedema—Dexamethasone—atopic dermatitis	0.000436	0.000626	CcSEcCtD
Fosaprepitant—Nausea—Tacrolimus—atopic dermatitis	0.000434	0.000623	CcSEcCtD
Fosaprepitant—Angiopathy—Prednisone—atopic dermatitis	0.000433	0.000622	CcSEcCtD
Fosaprepitant—Immune system disorder—Prednisone—atopic dermatitis	0.000431	0.000619	CcSEcCtD
Fosaprepitant—Malaise—Betamethasone—atopic dermatitis	0.00043	0.000618	CcSEcCtD
Fosaprepitant—Malaise—Dexamethasone—atopic dermatitis	0.00043	0.000618	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000429	0.000617	CcSEcCtD
Fosaprepitant—Oedema—Triamcinolone—atopic dermatitis	0.000429	0.000617	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000428	0.000615	CcSEcCtD
Fosaprepitant—Syncope—Betamethasone—atopic dermatitis	0.000428	0.000615	CcSEcCtD
Fosaprepitant—Syncope—Dexamethasone—atopic dermatitis	0.000428	0.000615	CcSEcCtD
Fosaprepitant—Infection—Triamcinolone—atopic dermatitis	0.000427	0.000613	CcSEcCtD
Fosaprepitant—Hypotension—Hydrocortisone—atopic dermatitis	0.000426	0.000612	CcSEcCtD
Fosaprepitant—Infection—Methylprednisolone—atopic dermatitis	0.000426	0.000611	CcSEcCtD
Fosaprepitant—Shock—Triamcinolone—atopic dermatitis	0.000422	0.000607	CcSEcCtD
Fosaprepitant—Insomnia—Prednisolone—atopic dermatitis	0.000422	0.000606	CcSEcCtD
Fosaprepitant—Shock—Methylprednisolone—atopic dermatitis	0.000421	0.000605	CcSEcCtD
Fosaprepitant—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.00042	0.000603	CcSEcCtD
Fosaprepitant—Loss of consciousness—Dexamethasone—atopic dermatitis	0.00042	0.000602	CcSEcCtD
Fosaprepitant—Loss of consciousness—Betamethasone—atopic dermatitis	0.00042	0.000602	CcSEcCtD
Fosaprepitant—Mental disorder—Prednisone—atopic dermatitis	0.000418	0.000601	CcSEcCtD
Fosaprepitant—Skin disorder—Methylprednisolone—atopic dermatitis	0.000416	0.000598	CcSEcCtD
Fosaprepitant—Erythema—Prednisone—atopic dermatitis	0.000416	0.000597	CcSEcCtD
Fosaprepitant—Malnutrition—Prednisone—atopic dermatitis	0.000416	0.000597	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000415	0.000596	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000414	0.000595	CcSEcCtD
Fosaprepitant—Insomnia—Hydrocortisone—atopic dermatitis	0.000412	0.000592	CcSEcCtD
Fosaprepitant—Hypertension—Dexamethasone—atopic dermatitis	0.000412	0.000592	CcSEcCtD
Fosaprepitant—Hypertension—Betamethasone—atopic dermatitis	0.000412	0.000592	CcSEcCtD
Fosaprepitant—Anxiety—Dexamethasone—atopic dermatitis	0.000405	0.000582	CcSEcCtD
Fosaprepitant—Anxiety—Betamethasone—atopic dermatitis	0.000405	0.000582	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000404	0.00133	CbGpPWpGaD
Fosaprepitant—Discomfort—Dexamethasone—atopic dermatitis	0.000402	0.000577	CcSEcCtD
Fosaprepitant—Discomfort—Betamethasone—atopic dermatitis	0.000402	0.000577	CcSEcCtD
Fosaprepitant—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000401	0.000576	CcSEcCtD
Fosaprepitant—Hypotension—Methylprednisolone—atopic dermatitis	0.0004	0.000575	CcSEcCtD
Fosaprepitant—Pain—Prednisolone—atopic dermatitis	0.000399	0.000573	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCL5—atopic dermatitis	0.000398	0.00131	CbGpPWpGaD
Fosaprepitant—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000396	0.000569	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000394	0.000565	CcSEcCtD
Fosaprepitant—Fatigue—Hydrocortisone—atopic dermatitis	0.000393	0.000565	CcSEcCtD
Fosaprepitant—Pain—Hydrocortisone—atopic dermatitis	0.00039	0.00056	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.00039	0.000559	CcSEcCtD
Fosaprepitant—Oedema—Dexamethasone—atopic dermatitis	0.00039	0.000559	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Betamethasone—atopic dermatitis	0.00039	0.000559	CcSEcCtD
Fosaprepitant—Oedema—Betamethasone—atopic dermatitis	0.00039	0.000559	CcSEcCtD
Fosaprepitant—Insomnia—Triamcinolone—atopic dermatitis	0.000388	0.000558	CcSEcCtD
Fosaprepitant—Insomnia—Methylprednisolone—atopic dermatitis	0.000387	0.000556	CcSEcCtD
Fosaprepitant—Infection—Dexamethasone—atopic dermatitis	0.000387	0.000556	CcSEcCtD
Fosaprepitant—Infection—Betamethasone—atopic dermatitis	0.000387	0.000556	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—IL2—atopic dermatitis	0.000386	0.00127	CbGpPWpGaD
Fosaprepitant—Ill-defined disorder—Prednisone—atopic dermatitis	0.000386	0.000554	CcSEcCtD
Fosaprepitant—Feeling abnormal—Prednisolone—atopic dermatitis	0.000385	0.000552	CcSEcCtD
Fosaprepitant—Anaemia—Prednisone—atopic dermatitis	0.000384	0.000552	CcSEcCtD
Fosaprepitant—Shock—Dexamethasone—atopic dermatitis	0.000383	0.00055	CcSEcCtD
Fosaprepitant—Shock—Betamethasone—atopic dermatitis	0.000383	0.00055	CcSEcCtD
Fosaprepitant—Dyspnoea—Triamcinolone—atopic dermatitis	0.000383	0.00055	CcSEcCtD
Fosaprepitant—Nervous system disorder—Betamethasone—atopic dermatitis	0.000382	0.000549	CcSEcCtD
Fosaprepitant—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000382	0.000549	CcSEcCtD
Fosaprepitant—Angioedema—Prednisone—atopic dermatitis	0.00038	0.000545	CcSEcCtD
Fosaprepitant—Dyspepsia—Triamcinolone—atopic dermatitis	0.000378	0.000543	CcSEcCtD
Fosaprepitant—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000377	0.000541	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000377	0.000541	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000377	0.000541	CcSEcCtD
Fosaprepitant—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000376	0.00054	CcSEcCtD
Fosaprepitant—Malaise—Prednisone—atopic dermatitis	0.000375	0.000538	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000373	0.000535	CcSEcCtD
Fosaprepitant—Syncope—Prednisone—atopic dermatitis	0.000373	0.000535	CcSEcCtD
Fosaprepitant—Urticaria—Prednisolone—atopic dermatitis	0.000371	0.000533	CcSEcCtD
Fosaprepitant—Fatigue—Triamcinolone—atopic dermatitis	0.00037	0.000532	CcSEcCtD
Fosaprepitant—Fatigue—Methylprednisolone—atopic dermatitis	0.000369	0.00053	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NGF—atopic dermatitis	0.000368	0.00121	CbGpPWpGaD
Fosaprepitant—Pain—Triamcinolone—atopic dermatitis	0.000367	0.000527	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000367	0.00121	CbGpPWpGaD
Fosaprepitant—Loss of consciousness—Prednisone—atopic dermatitis	0.000365	0.000525	CcSEcCtD
Fosaprepitant—Hypotension—Betamethasone—atopic dermatitis	0.000364	0.000523	CcSEcCtD
Fosaprepitant—Hypotension—Dexamethasone—atopic dermatitis	0.000364	0.000523	CcSEcCtD
Fosaprepitant—Urticaria—Hydrocortisone—atopic dermatitis	0.000362	0.00052	CcSEcCtD
Fosaprepitant—Body temperature increased—Hydrocortisone—atopic dermatitis	0.00036	0.000518	CcSEcCtD
Fosaprepitant—Abdominal pain—Hydrocortisone—atopic dermatitis	0.00036	0.000518	CcSEcCtD
Fosaprepitant—Hypertension—Prednisone—atopic dermatitis	0.000359	0.000515	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR5—atopic dermatitis	0.000358	0.00118	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000354	0.000508	CcSEcCtD
Fosaprepitant—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000353	0.000507	CcSEcCtD
Fosaprepitant—Anxiety—Prednisone—atopic dermatitis	0.000353	0.000506	CcSEcCtD
Fosaprepitant—Insomnia—Dexamethasone—atopic dermatitis	0.000352	0.000506	CcSEcCtD
Fosaprepitant—Insomnia—Betamethasone—atopic dermatitis	0.000352	0.000506	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000351	0.000505	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—IL2—atopic dermatitis	0.000351	0.00115	CbGpPWpGaD
Fosaprepitant—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.00035	0.000503	CcSEcCtD
Fosaprepitant—Discomfort—Prednisone—atopic dermatitis	0.00035	0.000502	CcSEcCtD
Fosaprepitant—Hypersensitivity—Prednisolone—atopic dermatitis	0.000344	0.000494	CcSEcCtD
Fosaprepitant—Dyspepsia—Dexamethasone—atopic dermatitis	0.000343	0.000492	CcSEcCtD
Fosaprepitant—Dyspepsia—Betamethasone—atopic dermatitis	0.000343	0.000492	CcSEcCtD
Fosaprepitant—Urticaria—Triamcinolone—atopic dermatitis	0.000341	0.00049	CcSEcCtD
Fosaprepitant—Urticaria—Methylprednisolone—atopic dermatitis	0.00034	0.000489	CcSEcCtD
Fosaprepitant—Body temperature increased—Triamcinolone—atopic dermatitis	0.000339	0.000487	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Prednisone—atopic dermatitis	0.000339	0.000487	CcSEcCtD
Fosaprepitant—Oedema—Prednisone—atopic dermatitis	0.000339	0.000487	CcSEcCtD
Fosaprepitant—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000339	0.000486	CcSEcCtD
Fosaprepitant—Decreased appetite—Betamethasone—atopic dermatitis	0.000339	0.000486	CcSEcCtD
Fosaprepitant—Decreased appetite—Dexamethasone—atopic dermatitis	0.000339	0.000486	CcSEcCtD
Fosaprepitant—Infection—Prednisone—atopic dermatitis	0.000337	0.000484	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000336	0.000483	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000336	0.000483	CcSEcCtD
Fosaprepitant—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000336	0.000482	CcSEcCtD
Fosaprepitant—Fatigue—Betamethasone—atopic dermatitis	0.000336	0.000482	CcSEcCtD
Fosaprepitant—Fatigue—Dexamethasone—atopic dermatitis	0.000336	0.000482	CcSEcCtD
Fosaprepitant—Shock—Prednisone—atopic dermatitis	0.000334	0.000479	CcSEcCtD
Fosaprepitant—Pain—Betamethasone—atopic dermatitis	0.000333	0.000478	CcSEcCtD
Fosaprepitant—Pain—Dexamethasone—atopic dermatitis	0.000333	0.000478	CcSEcCtD
Fosaprepitant—Nervous system disorder—Prednisone—atopic dermatitis	0.000333	0.000478	CcSEcCtD
Fosaprepitant—Skin disorder—Prednisone—atopic dermatitis	0.00033	0.000473	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Prednisone—atopic dermatitis	0.000328	0.000471	CcSEcCtD
Fosaprepitant—Asthenia—Hydrocortisone—atopic dermatitis	0.000327	0.00047	CcSEcCtD
Fosaprepitant—Pruritus—Hydrocortisone—atopic dermatitis	0.000323	0.000463	CcSEcCtD
Fosaprepitant—Feeling abnormal—Betamethasone—atopic dermatitis	0.000321	0.000461	CcSEcCtD
Fosaprepitant—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000321	0.000461	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000319	0.000457	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000319	0.000457	CcSEcCtD
Fosaprepitant—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000316	0.000454	CcSEcCtD
Fosaprepitant—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000316	0.000453	CcSEcCtD
Fosaprepitant—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000312	0.000448	CcSEcCtD
Fosaprepitant—Urticaria—Dexamethasone—atopic dermatitis	0.000309	0.000444	CcSEcCtD
Fosaprepitant—Urticaria—Betamethasone—atopic dermatitis	0.000309	0.000444	CcSEcCtD
Fosaprepitant—Dizziness—Prednisolone—atopic dermatitis	0.000309	0.000443	CcSEcCtD
Fosaprepitant—Asthenia—Triamcinolone—atopic dermatitis	0.000308	0.000442	CcSEcCtD
Fosaprepitant—Abdominal pain—Betamethasone—atopic dermatitis	0.000308	0.000442	CcSEcCtD
Fosaprepitant—Abdominal pain—Dexamethasone—atopic dermatitis	0.000308	0.000442	CcSEcCtD
Fosaprepitant—Body temperature increased—Betamethasone—atopic dermatitis	0.000308	0.000442	CcSEcCtD
Fosaprepitant—Body temperature increased—Dexamethasone—atopic dermatitis	0.000308	0.000442	CcSEcCtD
Fosaprepitant—Asthenia—Methylprednisolone—atopic dermatitis	0.000307	0.000441	CcSEcCtD
Fosaprepitant—Insomnia—Prednisone—atopic dermatitis	0.000307	0.000441	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000304	0.001	CbGpPWpGaD
Fosaprepitant—Pruritus—Triamcinolone—atopic dermatitis	0.000304	0.000436	CcSEcCtD
Fosaprepitant—Pruritus—Methylprednisolone—atopic dermatitis	0.000303	0.000435	CcSEcCtD
Fosaprepitant—Dizziness—Hydrocortisone—atopic dermatitis	0.000302	0.000433	CcSEcCtD
Fosaprepitant—Dyspepsia—Prednisone—atopic dermatitis	0.000299	0.000429	CcSEcCtD
Fosaprepitant—Decreased appetite—Prednisone—atopic dermatitis	0.000295	0.000423	CcSEcCtD
Fosaprepitant—Rash—Prednisolone—atopic dermatitis	0.000294	0.000423	CcSEcCtD
Fosaprepitant—Dermatitis—Prednisolone—atopic dermatitis	0.000294	0.000422	CcSEcCtD
Fosaprepitant—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000293	0.000421	CcSEcCtD
Fosaprepitant—Fatigue—Prednisone—atopic dermatitis	0.000293	0.00042	CcSEcCtD
Fosaprepitant—Headache—Prednisolone—atopic dermatitis	0.000292	0.00042	CcSEcCtD
Fosaprepitant—Constipation—Prednisone—atopic dermatitis	0.00029	0.000417	CcSEcCtD
Fosaprepitant—Vomiting—Hydrocortisone—atopic dermatitis	0.00029	0.000416	CcSEcCtD
Fosaprepitant—Rash—Hydrocortisone—atopic dermatitis	0.000288	0.000413	CcSEcCtD
Fosaprepitant—Dermatitis—Hydrocortisone—atopic dermatitis	0.000287	0.000412	CcSEcCtD
Fosaprepitant—Headache—Hydrocortisone—atopic dermatitis	0.000286	0.00041	CcSEcCtD
Fosaprepitant—Dizziness—Triamcinolone—atopic dermatitis	0.000284	0.000408	CcSEcCtD
Fosaprepitant—Dizziness—Methylprednisolone—atopic dermatitis	0.000283	0.000407	CcSEcCtD
Fosaprepitant—Feeling abnormal—Prednisone—atopic dermatitis	0.00028	0.000401	CcSEcCtD
Fosaprepitant—Asthenia—Dexamethasone—atopic dermatitis	0.00028	0.000401	CcSEcCtD
Fosaprepitant—Asthenia—Betamethasone—atopic dermatitis	0.00028	0.000401	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000277	0.000398	CcSEcCtD
Fosaprepitant—Nausea—Prednisolone—atopic dermatitis	0.000277	0.000398	CcSEcCtD
Fosaprepitant—Pruritus—Betamethasone—atopic dermatitis	0.000276	0.000396	CcSEcCtD
Fosaprepitant—Pruritus—Dexamethasone—atopic dermatitis	0.000276	0.000396	CcSEcCtD
Fosaprepitant—Vomiting—Triamcinolone—atopic dermatitis	0.000273	0.000392	CcSEcCtD
Fosaprepitant—Vomiting—Methylprednisolone—atopic dermatitis	0.000272	0.000391	CcSEcCtD
Fosaprepitant—Nausea—Hydrocortisone—atopic dermatitis	0.000271	0.000389	CcSEcCtD
Fosaprepitant—Rash—Triamcinolone—atopic dermatitis	0.000271	0.000389	CcSEcCtD
Fosaprepitant—Dermatitis—Triamcinolone—atopic dermatitis	0.00027	0.000388	CcSEcCtD
Fosaprepitant—Rash—Methylprednisolone—atopic dermatitis	0.00027	0.000388	CcSEcCtD
Fosaprepitant—Dermatitis—Methylprednisolone—atopic dermatitis	0.00027	0.000388	CcSEcCtD
Fosaprepitant—Urticaria—Prednisone—atopic dermatitis	0.00027	0.000387	CcSEcCtD
Fosaprepitant—Headache—Triamcinolone—atopic dermatitis	0.000269	0.000386	CcSEcCtD
Fosaprepitant—Headache—Methylprednisolone—atopic dermatitis	0.000268	0.000385	CcSEcCtD
Fosaprepitant—Abdominal pain—Prednisone—atopic dermatitis	0.000268	0.000385	CcSEcCtD
Fosaprepitant—Body temperature increased—Prednisone—atopic dermatitis	0.000268	0.000385	CcSEcCtD
Fosaprepitant—Diarrhoea—Dexamethasone—atopic dermatitis	0.000267	0.000383	CcSEcCtD
Fosaprepitant—Diarrhoea—Betamethasone—atopic dermatitis	0.000267	0.000383	CcSEcCtD
Fosaprepitant—Dizziness—Dexamethasone—atopic dermatitis	0.000258	0.00037	CcSEcCtD
Fosaprepitant—Dizziness—Betamethasone—atopic dermatitis	0.000258	0.00037	CcSEcCtD
Fosaprepitant—Nausea—Triamcinolone—atopic dermatitis	0.000255	0.000366	CcSEcCtD
Fosaprepitant—Nausea—Methylprednisolone—atopic dermatitis	0.000254	0.000365	CcSEcCtD
Fosaprepitant—Hypersensitivity—Prednisone—atopic dermatitis	0.00025	0.000359	CcSEcCtD
Fosaprepitant—Vomiting—Dexamethasone—atopic dermatitis	0.000248	0.000356	CcSEcCtD
Fosaprepitant—Vomiting—Betamethasone—atopic dermatitis	0.000248	0.000356	CcSEcCtD
Fosaprepitant—Rash—Dexamethasone—atopic dermatitis	0.000246	0.000353	CcSEcCtD
Fosaprepitant—Rash—Betamethasone—atopic dermatitis	0.000246	0.000353	CcSEcCtD
Fosaprepitant—Dermatitis—Betamethasone—atopic dermatitis	0.000245	0.000352	CcSEcCtD
Fosaprepitant—Dermatitis—Dexamethasone—atopic dermatitis	0.000245	0.000352	CcSEcCtD
Fosaprepitant—Headache—Dexamethasone—atopic dermatitis	0.000244	0.00035	CcSEcCtD
Fosaprepitant—Headache—Betamethasone—atopic dermatitis	0.000244	0.00035	CcSEcCtD
Fosaprepitant—Asthenia—Prednisone—atopic dermatitis	0.000243	0.00035	CcSEcCtD
Fosaprepitant—Pruritus—Prednisone—atopic dermatitis	0.00024	0.000345	CcSEcCtD
Fosaprepitant—Diarrhoea—Prednisone—atopic dermatitis	0.000232	0.000333	CcSEcCtD
Fosaprepitant—Nausea—Betamethasone—atopic dermatitis	0.000231	0.000332	CcSEcCtD
Fosaprepitant—Nausea—Dexamethasone—atopic dermatitis	0.000231	0.000332	CcSEcCtD
Fosaprepitant—Dizziness—Prednisone—atopic dermatitis	0.000224	0.000322	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CXCL8—atopic dermatitis	0.000217	0.000714	CbGpPWpGaD
Fosaprepitant—Vomiting—Prednisone—atopic dermatitis	0.000216	0.00031	CcSEcCtD
Fosaprepitant—Rash—Prednisone—atopic dermatitis	0.000214	0.000307	CcSEcCtD
Fosaprepitant—Dermatitis—Prednisone—atopic dermatitis	0.000214	0.000307	CcSEcCtD
Fosaprepitant—Headache—Prednisone—atopic dermatitis	0.000213	0.000305	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—IL2—atopic dermatitis	0.000207	0.000682	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6—atopic dermatitis	0.000206	0.000679	CbGpPWpGaD
Fosaprepitant—Nausea—Prednisone—atopic dermatitis	0.000202	0.000289	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—MAPK8—atopic dermatitis	0.000191	0.000628	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6—atopic dermatitis	0.000122	0.000401	CbGpPWpGaD
